Top Markets
#1 Tutorial Tutorial +48.26%
#2 Official Trump Official Trump +26.06%
#3 Siacoin Siacoin +22.93%
#4 Pump.fun Pump.fun +22.71%
#5 Unit Pump Unit Pump +22.71%
#6 EXOD EXOD +18.93%
#7 Stacks Stacks +18.84%
#8 MowCat MowCat +18.19%
#9 LayerZero LayerZero +17.67%
#10 Melania Meme Melania Meme +16.87%
Coin of the day
Tutorial Tutorial
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Energenesis Biomedical CO.,LTD. Energenesis Biomedical CO.,LTD.

Energenesis Biomedical CO.,LTD.

6657
Classifica tra le azioni #22642
Energenesis Biomedical CO.,LTD., a firm established in 2012 and headquartered... Energenesis Biomedical CO.,LTD., a firm established in 2012 and headquartered in Taipei, Taiwan, is an active participant in the biomedicine sector. The company specializes in the development of a diverse range of medical solutions and research materials. Its primary pharmaceutical pipeline includes ENERGI-F703, which is currently undergoing Phase II clinical trials for the treatment of diabetic foot ulcers, and ENERGI-F701, a topical solution for addressing alopecia that is also in its second phase of clinical assessment. The comprehensive portfolio of therapeutic agents further encompasses: ENERGI-F711, formulated as a cream for burns. ENERGI-F702, designed to combat metabolic diseases. ENERGI-F704, targeting inflammatory bowel disease. ENERGI-F708, for the management of asthma. ENERGI-F705, aimed at controlling Parkinson's disease. ENERGI-F707, addressing mitochondrial deficiencies. ENERGI-F706, used to treat cachexia. ENERGI-F709, which serves as a vaccine adjuvant. ENERGI-F710, intended for the regulation of blood phosphate levels. Beyond its therapeutic developments, Energenesis Biomedical also provides a selection of scientific research products, including reagents for Western blotting, cell culture supplements, components for protein isolation and quantification, various laboratory dyes, and buffer solutions.
Prezzo delle azioni
$0.97305026
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$85.54M
Variazione (1 giorno)
1.16%
Variazione (1 anno)
-50.40%
Paese
TW
Scambia Energenesis Biomedical CO.,LTD. (6657)

Categoria

Healthcare
Ricavi di Energenesis Biomedical CO.,LTD. (6657)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Energenesis Biomedical CO.,LTD., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Energenesis Biomedical CO.,LTD. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH